Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China SFDA Revokes Licenses Of Two Makers Of Tainted Gel Capsules

This article was originally published in PharmAsia News

Executive Summary

China’s State FDA revoked the licenses of two producers of gel capsules involved in a scandal involving contaminated medicines.

China’s State FDA revoked the licenses of two producers of gel capsules involved in a scandal involving contaminated medicines. SFDA said it has ordered authorities in Zhegiang Province to revoke the licenses of Huaxing and Zhuokang, two makers of gel capsules suspected of containing chromium, a toxic and carcinogen when ingested in excessive amounts. The agency also said employees at the plants suspected of criminal offenses would face criminal charges. (Click here for more)

“Authority Revokes Two Gel Capsule Producers’ Licenses” Xinhua (China) (4/19/12)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC080875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel